Cargando…
Sex Differences in Reported Adverse Drug Reactions to Angiotensin-Converting Enzyme Inhibitors
This cross-sectional study investigates differences by sex in reporting of adverse drug reactions associated with angiotensin-converting enzyme inhibitors combining global and prescription-corrected databases.
Autores principales: | Bots, Sophie H., Schreuder, Michelle M., Roeters van Lennep, Jeanine E., Watson, Sarah, van Puijenbroek, Eugène, Onland-Moret, N. Charlotte, den Ruijter, Hester M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021909/ https://www.ncbi.nlm.nih.gov/pubmed/35442456 http://dx.doi.org/10.1001/jamanetworkopen.2022.8224 |
Ejemplares similares
-
Addressing persistent evidence gaps in cardiovascular sex differences research – the potential of clinical care data
por: Bots, Sophie H., et al.
Publicado: (2023) -
Integration of sex and gender in cardiovascular medicine: a scientific and clinical imperative
por: Kavousi, Maryam, et al.
Publicado: (2023) -
Angiotensin-converting enzyme 2, sex differences, and COVID-19: The missing link
por: Van den Eynde, Jef, et al.
Publicado: (2021) -
Adverse Events Associated With PCSK9 Inhibitors: A Real‐World Experience
por: Gürgöze, Muhammed T., et al.
Publicado: (2018) -
The effect of age on blood pressure response by 4‐week treatment perindopril: A pooled sex‐specific analysis of the EUROPA, PROGRESS, and ADVANCE trials
por: Schreuder, Michelle M., et al.
Publicado: (2021)